Officer Dennis Mulroy Files Intent to Sell Additional $1.03M in Stock

summarizeSummary

AnaptysBio officer Dennis Mulroy has filed a Form 144 indicating intent to sell an additional $1.03 million worth of common stock, continuing a recent trend of significant share dispositions by the executive.

check_boxKey Events

• Officer Files Intent to Sell

  Officer Dennis Mulroy has filed a Form 144 indicating intent to sell 20,000 shares of common stock, with an approximate market value of $1,033,096.00. These shares were acquired via stock option exercise on the same day as the proposed sale.

• Continuation of Selling Pattern

  This filing extends a recent trend of significant share dispositions by Dennis Mulroy, marking the fourth Form 144 filed by this officer in the past week. Cumulatively, Mulroy has indicated intent to sell or has sold 98,422 shares for gross proceeds of $5,747,543.52 in the last three months, in addition to this new proposed sale.

• Context of Recent Corporate Actions

  This ongoing insider selling follows the company's recent spin-off of First Tracks Biotherapeutics and the announcement of a new $100 million share repurchase program, which was intended to return value to shareholders.

auto_awesomeAnalysis

This Form 144 filing indicates an officer's intent to sell an additional $1.03 million worth of company stock. This is part of a clear and ongoing pattern of significant share dispositions by this officer, Dennis Mulroy, who has filed multiple Form 144s in recent weeks, cumulatively totaling over $6.7 million in proposed and past sales within the last three months. This consistent selling by a key executive, even if related to option exercises, suggests a continued distribution of holdings following the company's recent spin-off and share repurchase program.